Santhera Pharmaceuticals Holding AG (LON:0QN1)
London
· Delayed Price · Currency is GBP · Price in CHF 12.18
+0.58 (5.00%)
At close: Jun 20, 2025
Santhera Pharmaceuticals Holding AG Employees
Santhera Pharmaceuticals Holding AG had 79 employees as of December 31, 2024. The number of employees increased by 34 or 75.22% compared to the previous year.
Employees
79
Change (1Y)
34
Growth (1Y)
75.22%
Revenue / Employee
436.46K GBP
Profits / Employee
-468.34K GBP
Market Cap
143.60M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| HUTCHMED (China) | 1,811 |
| Indivior | 1,051 |
Santhera Pharmaceuticals Holding AG News
- 2 months ago - Santhera Pharmaceuticals reports FY results - Seeking Alpha
- 3 months ago - Santhera Pharmaceuticals reports FY results - Seeking Alpha
- 5 months ago - Santhera Pharmaceuticals Provides Update on Royalty Agreement for AGAMREE® (Vamorolone) and Warrants held by Idorsia - GlobeNewsWire
- 6 months ago - Santhera Enters into Supply and Distribution Agreement for AGAMREE® (Vamorolone) with Clinigen Group - GlobeNewsWire
- 6 months ago - Santhera Announces Approval from China's NMPA for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy - Benzinga
- 10 months ago - Santhera Enters into an Exclusive Distribution Agreement with GENESIS Pharma for AGAMREE® (Vamorolone) in Central and Eastern Europe - GlobeNewsWire